Assetmark Inc. increased its position in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 70.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,736 shares of the real estate investment trust's stock after buying an additional 27,520 shares

Rhumbline Advisers lessened its stake in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 5.8% during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 824,077 shares of the real estate investment trust's stock after selling 50,284 shares during the quarter. Rhumbline Advisers owned approximately 0.34% of

Sabra Healthcare REIT (NASDAQ: SBRA) executives told investors the company expects continued growth in 2026, citing improving senior housing operating fundamentals, steady leverage, and what management described as a robust investment pipeline that should exceed 2025 volume. 2026 outlook centers on SHOP growth and transition facility improvement CEO Rick Matros said net operating income (NOI) growth

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the company's Chief Financial Officer; Darrin Smith, the company's Chief Investment Officer; and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2026 Global Property CEO Conference on March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. About Sabra Sabra Health Care REI.

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2025. FOURTH QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2025 were as follows: Net Income: $0.11 FFO: $0.36 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.38x Senior Housing - Leased: 1.52x Beh.

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.

Cornerstone Wealth Management LLC boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 256.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 39,781 shares of the real estate investment trust's stock after purchasing an additional 28,625 shares during

Sabra Health Care REIT is rated Buy, with substantial upside driven by its accelerated transition to the SHOP operating model and attractive valuation. SBRA targets 40% SHOP portfolio exposure, expecting to exceed their up to $500M investment guidance, positioning for robust growth into 2026. Normalized AFFO guidance for 2025 is $1.495/share, with an 80% payout ratio supporting a 6.38% dividend yield and potential for future increases.